Stifel maintains Hold on Biogen (NASDAQ: BIIB), keeps price target of $298.00.Analyst Thomas Shrader comments "We value Biogen based on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE